Implications of the changing face of Clostridium difficile disease for health care practitioners.
about
Systematic review and meta-analysis of Saccharomyces boulardii in adult patientsSystematic review: faecal transplantation for the treatment of Clostridium difficile-associated diseaseEpidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative ReviewAsymptomatic Clostridium difficile colonization: epidemiology and clinical implicationsImproved eradication of Clostridium difficile spores from toilets of hospitalized patients using an accelerated hydrogen peroxide as the cleaning agent.Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands.Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel diseaseRifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial.Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model.PrsW is required for colonization, resistance to antimicrobial peptides, and expression of extracytoplasmic function σ factors in Clostridium difficile.Emergence of an outbreak-associated Clostridium difficile variant with increased virulence.Rifaximin Is Effective for the Treatment of Clostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study.Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?Epidemiological model for Clostridium difficile transmission in healthcare settings.Clostridium difficile infection: a re-emerging threat.Toxinotype V Clostridium difficile in humans and food animals.Clostridium difficile in ready-to-eat salads, ScotlandAntibiotic-associated diarrhea: epidemiology, trends and treatment.Is there a future for probiotics in preventing Clostridium difficile-associated disease and treatment of recurrent episodes?Control of antibiotic-resistant bacteria in the office and clinic.Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cellsClostridium difficile in paediatric populations.Emerging therapies for Clostridium difficile infections.Primary prevention of Clostridium difficile infections - how difficult can it be?Therapies on the horizon for Clostridium difficile infections.Inhibition of Clostridium difficile in Mice Using a Mixture of Potential Probiotic Strains Enterococcus faecalis NM815, E. faecalis NM915, and E. faecium NM1015: Novel Candidates to Control C. difficile Infection (CDI).A Novel Fic (Filamentation Induced by cAMP) Protein from Clostridium difficile Reveals an Inhibitory Motif-independent Adenylylation/AMPylation Mechanism.Anti-Clostridium difficile potential of tetramic acid derivatives from Pseudomonas aeruginosa quorum-sensing autoinducersDiarrhoea associated with antibiotic use.Reply to McDonald.Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.Le Clostridium difficile dans les populations d’âge pédiatrique.The changing face of Clostridium difficile: what treatment options remain?Clostridium difficile - From Colonization to Infection.Prevalence of Clostridium difficile in raw cow, sheep, and goat meat in Jazan, Saudi Arabia.Effects of antibiotic therapy on the gastrointestinal microbiota and the influence ofLactobacillus casei
P2860
Q24621081-4BFE6B0B-5149-4D12-BE80-92502124CAB3Q26851409-EA277797-D181-4B1F-9702-2B2C85631617Q28073805-D7218BB0-F0AD-4D8F-BEAE-B0AD7FD38A23Q28083860-EE1424DD-EA8D-4A75-9929-A84B99FF0072Q33693310-C0EB33E5-EF71-47BB-85AC-B53D04658A75Q34112832-109C9180-7618-4028-A0DA-AFB7CD166CAAQ34118034-4C4C1C48-7EC2-4211-9C35-2828CC878E8CQ34409185-9A3D0898-D6BC-44E3-BF8D-D63A6B9A4C5BQ34943390-C515C5D4-A817-45B7-A3E2-53EBA4943D90Q35139342-E2BB2AD8-5506-41B2-B224-B25FEE7884F5Q35193183-47E4E63A-C302-4DCD-B8D7-7E42CA95F0D4Q35550741-EE678772-9A3C-4EB4-8966-90616ACC0C8CQ36396899-9379DBE8-531F-4AB6-947C-4AE9306A48CCQ36515597-C53D0304-BE97-43E5-B073-CFEBB777C45DQ36818407-F9CAC23E-7789-4FE4-83C3-C49EB6EC346BQ36827540-F885E8BB-F928-4097-A35F-4DC04A01FE5CQ37070485-37E153F6-B5B6-4FF6-AD7B-5D6834C7512EQ37203796-AB122FFF-24AA-4F8D-AA8B-D9868DC8A2B4Q37277087-81779F16-87BA-4136-BFF2-CBE8AAEEA7C0Q37401582-3C1A25C6-BCD4-44B0-A610-64D75BBFA2E1Q37477929-E312343C-7072-4596-89BA-5A485FFF24B0Q37550108-B3CB4F05-E1BD-494C-9D8D-E719CE6E6326Q37609568-67A55C29-CA91-4107-965C-3FED05BD8789Q37858531-E772F173-AEF1-484F-8800-8200C663944EQ38739075-272A4C6F-3D35-46E2-977A-E0CD500E2674Q38757930-B68279C6-EB7A-443B-8914-3389A526A47AQ40215869-7C1DA0A9-0DB7-45B5-AD46-DC8444E2257CQ40715444-14CB20A5-39B5-42BC-A2CB-A914F6A7A2A1Q42057286-E6B8C877-9851-4F0E-A6A2-C57B67DFB314Q42592374-3253C81D-5F38-4304-A573-89C05476A052Q43234694-D69C5EE9-3E80-44E4-A119-54E6221E066BQ45332183-FABB65A7-7814-4279-8EA4-C6A8CAE5AC60Q45919083-0F546921-7725-4948-8EF5-E513163BF42DQ46879857-790B7364-9E76-442D-B8F6-525D4BE47DEEQ52564641-4F4CC08F-A5FC-409C-99F6-E3E39EF6ED72Q54217673-C1E5B89B-B9EE-460F-AAB9-DDD467FC9683Q57226635-09E75935-83E4-4960-B057-828854B49B22
P2860
Implications of the changing face of Clostridium difficile disease for health care practitioners.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Implications of the changing f ...... for health care practitioners.
@ast
Implications of the changing f ...... for health care practitioners.
@en
type
label
Implications of the changing f ...... for health care practitioners.
@ast
Implications of the changing f ...... for health care practitioners.
@en
prefLabel
Implications of the changing f ...... for health care practitioners.
@ast
Implications of the changing f ...... for health care practitioners.
@en
P2093
P1476
Implications of the changing f ...... for health care practitioners.
@en
P2093
Gregory J Raugi
Henry W Beneda
Jill E Clarridge
Lynne V McFarland
P304
P356
10.1016/J.AJIC.2006.06.004
P577
2007-05-01T00:00:00Z